Species-specific FMRP regulation of RACK1 is critical for prenatal cortical development

Minjie Shen1, Carissa L Sirois1, Yu Guo1

  • 1Waisman Center, University of Wisconsin-Madison, Madison, WI 53705, USA; Department of Neuroscience, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53705, USA.

Neuron
|October 11, 2023
PubMed

Insights

Fragile X messenger ribonucleoprotein 1 protein (FMRP) deficiency impairs prenatal brain development, causing mitochondrial issues and hyperexcitability. Enhancing mitochondrial function may treat fragile X syndrome (FXS).

Area of Science:

  • Neuroscience
  • Developmental Biology
  • Genetics

Background:

  • Fragile X syndrome (FXS), an autism spectrum disorder, is caused by Fragile X messenger ribonucleoprotein 1 protein (FMRP) deficiency.
  • The precise role of FMRP in prenatal human brain development is not fully understood.

Purpose of the Study:

  • To investigate the role of FMRP in human and macaque prenatal brain development.
  • To identify molecular mechanisms underlying FMRP deficiency in neurons.

Main Methods:

  • Utilized human fetal cortical slices and patient-derived stem cells.
  • Performed multiomics analyses to identify FMRP-bound mRNAs and interacting proteins.
  • Investigated the function of RACK1 and mitochondrial enhancement in neuronal models.

Main Results:

  • FMRP deficiency in neurons leads to mitochondrial dysfunction and hyperexcitability.
  • Identified novel FMRP targets and interactions, revealing a role in regulating essential prenatal developmental genes.
  • Demonstrated that FMRP interaction with CNOT1 maintains RACK1 levels, and RACK1 reduction mimics FXS neuronal deficits.
  • Showed that enhancing mitochondrial function rescues prenatal neuronal deficits in FMRP-deficient models.

Conclusions:

  • FMRP is crucial for prenatal brain development, regulating essential genes.
  • Mitochondrial dysfunction and hyperexcitability are key features of FMRP deficiency.
  • Targeting mitochondrial dysfunction presents a potential therapeutic strategy for FXS.